Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment

Background: We evaluated the impact of prior statin use on successful reperfusion and stroke outcomes after endovascular treatment (EVT). Method: Using consecutive multicenter databases, we enrolled acute ischemic stroke patients receiving EVT between 2015 and 2021. Patients were classified into pri...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sang-Hwa Lee, Min Uk Jang, Yerim Kim, So Young Park, Chulho Kim, Yeo Jin Kim, Jong-Hee Sohn
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/516a0381786148aab2a26e0fa3784fa7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:516a0381786148aab2a26e0fa3784fa7
record_format dspace
spelling oai:doaj.org-article:516a0381786148aab2a26e0fa3784fa72021-11-11T17:46:20ZImpact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment10.3390/jcm102151472077-0383https://doaj.org/article/516a0381786148aab2a26e0fa3784fa72021-11-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/5147https://doaj.org/toc/2077-0383Background: We evaluated the impact of prior statin use on successful reperfusion and stroke outcomes after endovascular treatment (EVT). Method: Using consecutive multicenter databases, we enrolled acute ischemic stroke patients receiving EVT between 2015 and 2021. Patients were classified into prior statin users and no prior statin users after a review of premorbid medications. The primary outcome measure was successful reperfusion defined as modified TICI grade 2b or 3 after EVT. Secondary outcome measures were early neurologic deterioration (END) and a 3-month modified Rankin Scale (mRS) score of 0 to 2. Results: Among 385 patients receiving EVT, 74 (19.2%) were prior statin users, who had a significantly higher successful reperfusion rate compared with no prior statin users (94.6% versus 78.8%, <i>p</i> = 0.002). Successful reperfusion and END occurrence were improved according to statin intensity with a dose–response relationship. In multivariate analysis, prior statin was associated with successful reperfusion after EVT (adjusted odds ratio (95% confidence interval) 5.31 (1.67–16.86)). In addition, prior statin was associated with a lower occurrence of END and good functional status. Conclusion: Our study showed that prior statin use before ischemic stroke might improve successful reperfusion and stroke outcomes after EVT.Sang-Hwa LeeMin Uk JangYerim KimSo Young ParkChulho KimYeo Jin KimJong-Hee SohnMDPI AGarticleprior statinendovascular treatmentreperfusion rateearly neurologic deteriorationstroke outcomeMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5147, p 5147 (2021)
institution DOAJ
collection DOAJ
language EN
topic prior statin
endovascular treatment
reperfusion rate
early neurologic deterioration
stroke outcome
Medicine
R
spellingShingle prior statin
endovascular treatment
reperfusion rate
early neurologic deterioration
stroke outcome
Medicine
R
Sang-Hwa Lee
Min Uk Jang
Yerim Kim
So Young Park
Chulho Kim
Yeo Jin Kim
Jong-Hee Sohn
Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment
description Background: We evaluated the impact of prior statin use on successful reperfusion and stroke outcomes after endovascular treatment (EVT). Method: Using consecutive multicenter databases, we enrolled acute ischemic stroke patients receiving EVT between 2015 and 2021. Patients were classified into prior statin users and no prior statin users after a review of premorbid medications. The primary outcome measure was successful reperfusion defined as modified TICI grade 2b or 3 after EVT. Secondary outcome measures were early neurologic deterioration (END) and a 3-month modified Rankin Scale (mRS) score of 0 to 2. Results: Among 385 patients receiving EVT, 74 (19.2%) were prior statin users, who had a significantly higher successful reperfusion rate compared with no prior statin users (94.6% versus 78.8%, <i>p</i> = 0.002). Successful reperfusion and END occurrence were improved according to statin intensity with a dose–response relationship. In multivariate analysis, prior statin was associated with successful reperfusion after EVT (adjusted odds ratio (95% confidence interval) 5.31 (1.67–16.86)). In addition, prior statin was associated with a lower occurrence of END and good functional status. Conclusion: Our study showed that prior statin use before ischemic stroke might improve successful reperfusion and stroke outcomes after EVT.
format article
author Sang-Hwa Lee
Min Uk Jang
Yerim Kim
So Young Park
Chulho Kim
Yeo Jin Kim
Jong-Hee Sohn
author_facet Sang-Hwa Lee
Min Uk Jang
Yerim Kim
So Young Park
Chulho Kim
Yeo Jin Kim
Jong-Hee Sohn
author_sort Sang-Hwa Lee
title Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment
title_short Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment
title_full Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment
title_fullStr Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment
title_full_unstemmed Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment
title_sort impact of prior statin use on reperfusion rate and stroke outcomes in patients receiving endovascular treatment
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/516a0381786148aab2a26e0fa3784fa7
work_keys_str_mv AT sanghwalee impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment
AT minukjang impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment
AT yerimkim impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment
AT soyoungpark impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment
AT chulhokim impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment
AT yeojinkim impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment
AT jongheesohn impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment
_version_ 1718431999971033088